
NGS Sample Preparation Market by Product (Reagents & Consumables, Workstations), Workflow (DNA, Library Preparation, Quality Control), Technology, Application, End-User - Global Forecast 2024-2030
Description
NGS Sample Preparation Market by Product (Reagents & Consumables, Workstations), Workflow (DNA, Library Preparation, Quality Control), Technology, Application, End-User - Global Forecast 2024-2030
The NGS Sample Preparation Market size was estimated at USD 2.40 billion in 2023 and expected to reach USD 2.78 billion in 2024, at a CAGR 16.01% to reach USD 6.80 billion by 2030.Next Generation Sequencing (NGS) sample preparation is essential and primary step in library preparation and is necessary for various diagnostic analyses. The increasing complexity of laboratory workflows and the need to reduce sample processing time are raising the need for NGS sample preparation solutions. Growing applications of NGS in clinical diagnostics and personalized medicine are increasing the requirement for NGS sample preparation techniques. However, high hardware and software infrastructure costs may limit their adoption by the end users. Moreover, the technological advancements in NGS sample preparation platforms and ongoing collaborations between companies to develop NGS sample preparation platforms are expected to expand the usage of NGS sample preparation systems and solutions.
Regional Insights
The NGS sample preparation market is evolving in the Americas owing to the presence of a well-established pharmaceutical sector and local and international companies providing a wide range of products tailored to specific applications. These companies in the region offer a variety of sample preparation solutions ranging from reagents to automated platforms and provide end users with high-quality products that meet their specific requirements. The NGS Sample Preparation Market in APAC is growing owing to the rising prevalence of chronic diseases and the growing need for early detection and diagnosis of diseases. The NGS sample preparation market in Europe, the Middle East, and Africa (EMEA) is developing due to improved access to NGS technologies, associated infrastructure, and healthcare systems development. Additionally, increased investment in diagnostic testing capabilities and the development of innovative sample preparation platforms are expected to create lucrative opportunities to adopt NGS sample preparation solutions worldwide.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the NGS Sample Preparation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the NGS Sample Preparation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the NGS Sample Preparation Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied Biological Materials Inc., Aurora Biomed Inc., Beckman Coulter by Danaher Corporation, BGI Group, Bio-Rad Laboratories, Inc., BioDynami, Eppendorf SE, Eurofins Genomics LLC, F. Hoffmann-La Roche Ltd., FORMULATRIX, Inc., Illumina, Inc., Integrated DNA Technologies, Inc., Macrogen Inc., Magen Biotechnology Co., Ltd., MCLAB, Merck KGaA, New England Biolabs, Inc., Novogene Co., Ltd., Oxford Nanopore Technologies PLC, PerkinElmer Inc., Promega Corporation, Psomagen, Inc., Qiagen N.V., SPT Labtech Ltd, Standard BioTools Inc., Sysmex Corporation, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, and Zymo Research Corporation.
Market Segmentation & Coverage
This research report categorizes the NGS Sample Preparation Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Reagents & Consumables
Workstations
Workflow
DNA
Human Whole Genome Sequencing (WGS)
Targeted Sequencing
Whole Exome Sequencing (WES)
Library Preparation
Quality Control
RNA
Gene Expression Analysis
Whole Transcriptome Sequencing
Target Enrichment
Targeted Seq
WES
Whole Exome Sequencing (WES)
Technology
Ion Semiconductor Sequencing
Nanopore Sequencing
Sequencing by Synthesis (SBS)
Single-molecule real-time (SMRT) Sequencing
Application
Agricultural & Animal Research
Disease Diagnostics
Cancer Diagnostics
Infectious Disease Diagnostics
Reproductive Health Diagnostics
Drug Discovery
End-User
Academic Institutes and Research Centers
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the NGS Sample Preparation Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the NGS Sample Preparation Market?
3. What are the technology trends and regulatory frameworks in the NGS Sample Preparation Market?
4. What is the market share of the leading vendors in the NGS Sample Preparation Market?
5. Which modes and strategic moves are suitable for entering the NGS Sample Preparation Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
182 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. NGS Sample Preparation Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing prevalence of infectious diseases and rising need for early disease diagnosis
- 5.1.1.2. Favorable investment landscape in NGS for the research and development of new treatments
- 5.1.1.3. Emerging use of NGS sequencing technology in agriculture for sustainable productivity
- 5.1.2. Restraints
- 5.1.2.1. High cost of NGS sample preparation platforms and contamination issues during NGS sample preparation
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancement in NGS sample preparation platforms
- 5.1.3.2. Increasing collaboration and partnership among private and government organizations to develop NGS sample preparation platforms
- 5.1.4. Challenges
- 5.1.4.1. Limited availability of skilled professionals in medium and small size laboratories
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. NGS Sample Preparation Market, by Product
- 6.1. Introduction
- 6.2. Reagents & Consumables
- 6.3. Workstations
- 7. NGS Sample Preparation Market, by Workflow
- 7.1. Introduction
- 7.2. DNA
- 7.3.1. Human Whole Genome Sequencing (WGS)
- 7.3.2. Targeted Sequencing
- 7.3.3. Whole Exome Sequencing (WES)
- 7.3. Library Preparation
- 7.4. Quality Control
- 7.5. RNA
- 7.6.1. Gene Expression Analysis
- 7.6.2. Whole Transcriptome Sequencing
- 7.6. Target Enrichment
- 7.7.1. Targeted Seq
- 7.7.2. WES
- 7.7.3. Whole Exome Sequencing (WES)
- 8. NGS Sample Preparation Market, by Technology
- 8.1. Introduction
- 8.2. Ion Semiconductor Sequencing
- 8.3. Nanopore Sequencing
- 8.4. Sequencing by Synthesis (SBS)
- 8.5. Single-molecule real-time (SMRT) Sequencing
- 9. NGS Sample Preparation Market, by Application
- 9.1. Introduction
- 9.2. Agricultural & Animal Research
- 9.3. Disease Diagnostics
- 9.4.1. Cancer Diagnostics
- 9.4.2. Infectious Disease Diagnostics
- 9.4.3. Reproductive Health Diagnostics
- 9.4. Drug Discovery
- 10. NGS Sample Preparation Market, by End-User
- 10.1. Introduction
- 10.2. Academic Institutes and Research Centers
- 10.3. Hospitals & Clinics
- 10.4. Pharmaceutical & Biotechnology Companies
- 11. Americas NGS Sample Preparation Market
- 11.1. Introduction
- 11.2. Argentina
- 11.3. Brazil
- 11.4. Canada
- 11.5. Mexico
- 11.6. United States
- 12. Asia-Pacific NGS Sample Preparation Market
- 12.1. Introduction
- 12.2. Australia
- 12.3. China
- 12.4. India
- 12.5. Indonesia
- 12.6. Japan
- 12.7. Malaysia
- 12.8. Philippines
- 12.9. Singapore
- 12.10. South Korea
- 12.11. Taiwan
- 12.12. Thailand
- 12.13. Vietnam
- 13. Europe, Middle East & Africa NGS Sample Preparation Market
- 13.1. Introduction
- 13.2. Denmark
- 13.3. Egypt
- 13.4. Finland
- 13.5. France
- 13.6. Germany
- 13.7. Israel
- 13.8. Italy
- 13.9. Netherlands
- 13.10. Nigeria
- 13.11. Norway
- 13.12. Poland
- 13.13. Qatar
- 13.14. Russia
- 13.15. Saudi Arabia
- 13.16. South Africa
- 13.17. Spain
- 13.18. Sweden
- 13.19. Switzerland
- 13.20. Turkey
- 13.21. United Arab Emirates
- 13.22. United Kingdom
- 14. Competitive Landscape
- 14.1. FPNV Positioning Matrix
- 14.2. Market Share Analysis, By Key Player
- 14.3. Competitive Scenario Analysis, By Key Player
- 14.3.1. Merger & Acquisition
- 14.3.1.1. INTEGRA Biosciences Acquires Miroculus
- 14.3.1.2. QIAGEN completes acquisition of Verogen, strengthening leadership in Human ID / Forensics with NGS technologies
- 14.3.1.3. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
- 14.3.2. Agreement, Collaboration, & Partnership
- 14.3.2.1. Ultima Genomics Partners with New England Biolabs to Expand Research Applications on Ultima Sequencers
- 14.3.2.2. Beckman Coulter Life Sciences and Illumina Enter Into Application Development Agreement for the Biomek NGeniuS System
- 14.3.3. New Product Launch & Enhancement
- 14.3.3.1. Agilent enhances user experience in NGS sample preparation workflow
- 14.3.3.2. Integrated DNA Technologies Launches Complete NGS Library Preparation Solution for Monkeypox
- 14.3.3.3. NGS KAPA Target Enrichment Product Launch
- 14.3.3.4. PerkinElmer Launches BioQule NGS System to Automate Library Preparation
- 14.3.3.5. Introducing Tecan’s MagicPrep NGS – the walkaway solution for your NGS library prep needs
- 15. Competitive Portfolio
- 15.1. Key Company Profiles
- 15.1.1. Agilent Technologies, Inc.
- 15.1.2. Applied Biological Materials Inc.
- 15.1.3. Aurora Biomed Inc.
- 15.1.4. Beckman Coulter by Danaher Corporation
- 15.1.5. BGI Group
- 15.1.6. Bio-Rad Laboratories, Inc.
- 15.1.7. BioDynami
- 15.1.8. Eppendorf SE
- 15.1.9. Eurofins Genomics LLC
- 15.1.10. F. Hoffmann-La Roche Ltd.
- 15.1.11. FORMULATRIX, Inc.
- 15.1.12. Illumina, Inc.
- 15.1.13. Integrated DNA Technologies, Inc.
- 15.1.14. Macrogen Inc.
- 15.1.15. Magen Biotechnology Co., Ltd.
- 15.1.16. MCLAB
- 15.1.17. Merck KGaA
- 15.1.18. New England Biolabs, Inc.
- 15.1.19. Novogene Co., Ltd.
- 15.1.20. Oxford Nanopore Technologies PLC
- 15.1.21. PerkinElmer Inc.
- 15.1.22. Promega Corporation
- 15.1.23. Psomagen, Inc.
- 15.1.24. Qiagen N.V.
- 15.1.25. SPT Labtech Ltd
- 15.1.26. Standard BioTools Inc.
- 15.1.27. Sysmex Corporation
- 15.1.28. Takara Bio Inc.
- 15.1.29. Tecan Trading AG
- 15.1.30. Thermo Fisher Scientific Inc.
- 15.1.31. Twist Bioscience Corporation
- 15.1.32. Zymo Research Corporation
- 15.2. Key Product Portfolio
- 16. Appendix
- 16.1. Discussion Guide
- 16.2. License & Pricing
- FIGURE 1. NGS SAMPLE PREPARATION MARKET RESEARCH PROCESS
- FIGURE 2. NGS SAMPLE PREPARATION MARKET SIZE, 2023 VS 2030
- FIGURE 3. NGS SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. NGS SAMPLE PREPARATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. NGS SAMPLE PREPARATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. NGS SAMPLE PREPARATION MARKET DYNAMICS
- FIGURE 7. NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
- FIGURE 10. NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
- FIGURE 12. NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 14. NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 16. NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 20. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 25. NGS SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 26. NGS SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.